Billiontoone (NASDAQ:BLLN) Stock Price Down 5.7% – Here’s What Happened

06 Mar 2026, 14:14 by Danessa Lincoln · The Markets Daily

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report)’s share price dropped 5.7% on Wednesday . The stock traded as low as $77.55 and last traded at $78.40. Approximately 101,877 shares changed hands during trading, a decline of 57% from the average daily volume of 237,485 shares. The stock had previously closed at $83.14.

Billiontoone News Summary

Here are the key news stories impacting Billiontoone this week:

Positive Sentiment: Q4 beat — BillionToOne reported Q4 EPS of $0.11 vs. $0.04 consensus and revenue of $96.05M (vs. $85.85M est.), with revenue up 113% year-over-year — a clear operational beat that supports the stock rally. BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
Positive Sentiment: Raised 2026 revenue guidance — the company now guides FY2026 revenue to $430M–$445M vs. Street consensus near $356M, signaling stronger top-line trajectory and easing growth concerns. BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
Positive Sentiment: Management commentary and call highlights emphasize record revenue growth and strategic progress (product uptake, commercial execution) that underpin the bullish reaction. BillionToOne Inc (BLLN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic …
Neutral Sentiment: BTIG trimmed its price target from $160 to $140 but maintained a “buy” rating — a note that still supports upside but reduces one bullish price anchor. BTIG PT Lowered to $140
Neutral Sentiment: Short-interest reports are inconsistent/flat (data shows 0 shares / 0.0 days), making them unreliable as a near-term driver — currently no clear short squeeze signal.
Negative Sentiment: Wells Fargo lowered its price target to $90 and moved to “equal weight,” a bearish analyst action that could cap near-term gains if other firms follow. Wells Fargo lowed PT to $90
Positive Sentiment: Guggenheim reaffirmed a “buy” and $120 target, providing counterbalance among sell-side views. Guggenheim reaffirmed buy

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Wells Fargo & Company cut their target price on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a research note on Thursday. JPMorgan Chase & Co. dropped their price target on Billiontoone from $150.00 to $145.00 and set an “overweight” rating on the stock in a report on Wednesday, December 10th. BTIG Research reduced their price objective on Billiontoone from $160.00 to $140.00 and set a “buy” rating for the company in a research note on Thursday. William Blair started coverage on Billiontoone in a research report on Monday, December 1st. They set an “outperform” rating for the company. Finally, Piper Sandler reissued an “overweight” rating on shares of Billiontoone in a report on Wednesday, December 10th. Six research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Billiontoone presently has an average rating of “Moderate Buy” and an average target price of $129.57.

Get Our Latest Report on BLLN

Billiontoone Stock Performance

The company has a 50 day simple moving average of $85.87. The stock has a market cap of $3.30 billion and a P/E ratio of 721.70.

Billiontoone (NASDAQ:BLLN – Get Free Report) last announced its quarterly earnings data on Wednesday, March 4th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.07. The firm had revenue of $96.05 million during the quarter, compared to the consensus estimate of $85.85 million. The business’s quarterly revenue was up 113.0% on a year-over-year basis.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Rossby Financial LCC bought a new stake in Billiontoone during the 4th quarter valued at $25,000. Wells Fargo & Company MN bought a new stake in shares of Billiontoone during the 4th quarter valued at $76,000. Smartleaf Asset Management LLC purchased a new stake in Billiontoone during the 4th quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in Billiontoone in the 4th quarter worth about $82,000. Finally, Renaissance Capital LLC purchased a new position in Billiontoone during the 4th quarter valued at about $201,000.

Billiontoone Company Profile

(Get Free Report)

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.